Investigational Therapy Shows Promise for Guillain-Barré Syndrome in Late-Stage Testing
As reported on Newsweek, a novel experimental treatment for Guillain-Barré syndrome (GBS) may represent a major advance for patients living with the rare neurological disorder. New findings released by biotechnology…